These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 10564926

  • 1. Late effects in ankylosing spondylitis patients treated with 224Ra.
    Wick RR, Nekolla EA, Gössner W, Kellerer AM.
    Radiat Res; 1999 Dec; 152(6 Suppl):S8-S11. PubMed ID: 10564926
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Long-term investigation of the risk of malignant diseases following intravenous radium-224 treatment for ankylosing spondylitis].
    Schulte TL, Nekolla EA, Wick RR.
    Strahlenther Onkol; 2009 Sep; 185(9):549-56. PubMed ID: 19756420
    [Abstract] [Full Text] [Related]

  • 5. Life-span study on late effects of 224Ra in children and adults.
    Spiess H.
    Health Phys; 2010 Sep; 99(3):286-91. PubMed ID: 20699688
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 224Ra: risk to bone and haematopoietic tissue in ankylosing spondylitis patients.
    Wick RR, Chmelevsky D, Gössner W.
    Strahlentherapie Sonderb; 1985 Sep; 80():38-44. PubMed ID: 4095735
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Follow-up study of late effects in 224Ra treated ankylosing spondylitis patients.
    Wick RR, Gössner W.
    Health Phys; 1983 Sep; 44 Suppl 1():187-95. PubMed ID: 6862898
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Leukemia mortality after X-ray treatment for ankylosing spondylitis.
    Weiss HA, Darby SC, Fearn T, Doll R.
    Radiat Res; 1995 Apr; 142(1):1-11. PubMed ID: 7899552
    [Abstract] [Full Text] [Related]

  • 14. The reverse protraction factor in the induction of bone sarcomas in radium-224 patients.
    Chmelevsky D, Spiess H, Mays CW, Kellerer AM.
    Radiat Res; 1990 Oct; 124(1 Suppl):S69-79. PubMed ID: 2236514
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 18. Radiation-induced myelomatosis.
    Cuzick J.
    N Engl J Med; 1981 Jan 22; 304(4):204-10. PubMed ID: 7442744
    [Abstract] [Full Text] [Related]

  • 19. Bone sarcoma cumulative tumor rates in patients injected with 224Ra.
    Mays CW, Spiess H, Chmelevsky D, Kellerer A.
    Strahlentherapie Sonderb; 1985 Jan 22; 80():27-31. PubMed ID: 4095733
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.